- Home
- PUMP vs DCTH Comparison
PUMP vs DCTH Comparison
Compare PUMP & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PUMP
- DCTH
- Stock Information
- Founded
- PUMP 2007
- DCTH 1988
- Country
- PUMP United States
- DCTH United States
- Employees
- PUMP N/A
- DCTH N/A
- Industry
- PUMP Oilfield Services/Equipment
- DCTH Medical/Dental Instruments
- Sector
- PUMP Energy
- DCTH Health Care
- Exchange
- PUMP Nasdaq
- DCTH Nasdaq
- Market Cap
- PUMP 550.9M
- DCTH 630.4M
- IPO Year
- PUMP 2017
- DCTH N/A
- Fundamental
- Price
- PUMP $6.55
- DCTH $13.85
- Analyst Decision
- PUMP Buy
- DCTH Strong Buy
- Analyst Count
- PUMP 5
- DCTH 4
- Target Price
- PUMP $9.75
- DCTH $24.00
- AVG Volume (30 Days)
- PUMP 1.5M
- DCTH 508.4K
- Earning Date
- PUMP 07-30-2025
- DCTH 08-04-2025
- Dividend Yield
- PUMP N/A
- DCTH N/A
- EPS Growth
- PUMP N/A
- DCTH N/A
- EPS
- PUMP N/A
- DCTH N/A
- Revenue
- PUMP $1,397,859,000.00
- DCTH $53,850,000.00
- Revenue This Year
- PUMP N/A
- DCTH $155.42
- Revenue Next Year
- PUMP $9.57
- DCTH $37.93
- P/E Ratio
- PUMP N/A
- DCTH N/A
- Revenue Growth
- PUMP N/A
- DCTH 1068.87
- 52 Week Low
- PUMP $4.61
- DCTH $7.17
- 52 Week High
- PUMP $11.17
- DCTH $18.23
- Technical
- Relative Strength Index (RSI)
- PUMP 62.13
- DCTH 37.03
- Support Level
- PUMP $6.28
- DCTH $15.72
- Resistance Level
- PUMP $6.89
- DCTH $17.35
- Average True Range (ATR)
- PUMP 0.31
- DCTH 0.74
- MACD
- PUMP 0.08
- DCTH -0.40
- Stochastic Oscillator
- PUMP 78.48
- DCTH 2.23
About PUMP ProPetro Holding Corp.
ProPetro Holding Corp is a Texas-based oilfield services company. It provides hydraulic fracturing, wireline, and other complementary services to oil and gas companies engaged in the exploration and production of North American oil and natural gas resources. The company focused on the Permian Basin. The operating segments of the company are hydraulic fracturing which generates key revenue, wireline, cementing, and power generation service.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.